ML19240B518: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
Line 2: Line 2:
| number = ML19240B518
| number = ML19240B518
| issue date = 08/28/2019
| issue date = 08/28/2019
| title = 09/12/2019 Public Teleconference Meeting with Exubrion Therapeutics, Inc
| title = Public Teleconference Meeting with Exubrion Therapeutics, Inc
| author name =  
| author name =  
| author affiliation = NRC/NMSS
| author affiliation = NRC/NMSS
Line 16: Line 16:


=Text=
=Text=
{{#Wiki_filter:PUBLIC MEETING ANNOUNCEMENT Title:               Public Teleconference Meeting with Exubrion Therapeutics, Inc.
{{#Wiki_filter:
 
==PUBLIC MEETING ANNOUNCEMENT==
 
==Title:==
Public Teleconference Meeting with Exubrion Therapeutics, Inc.
Date(s) and Time(s): September 12, 2019, 01:00 PM to 02:00 PM Location:            Teleconference Category:            This is a Category 1 meeting. The public is invited to observe this meeting and will have one or more opportunities to communicate with the NRC after the business portion of the meeting but before the meeting is adjourned.
Date(s) and Time(s): September 12, 2019, 01:00 PM to 02:00 PM Location:            Teleconference Category:            This is a Category 1 meeting. The public is invited to observe this meeting and will have one or more opportunities to communicate with the NRC after the business portion of the meeting but before the meeting is adjourned.
Purpose:             The purpose of the meeting is to review options for Exubrion Therapeutics, Inc.'s continued discussions on the use of Sn-117m in dogs for the treatment of osteoarthritis.
 
Contact:             Irene Wu 301-415-1951 Irene.Wu@nrc.gov Participants:       NRC Office of Nuclear Material Safety and Safeguards Bridge Number              Pass Code Teleconference:
==Purpose:==
The purpose of the meeting is to review options for Exubrion Therapeutics, Inc.'s continued discussions on the use of Sn-117m in dogs for the treatment of osteoarthritis.
 
==Contact:==
Irene Wu 301-415-1951 Irene.Wu@nrc.gov
 
==Participants:==
NRC Office of Nuclear Material Safety and Safeguards Bridge Number              Pass Code Teleconference:
(888) 677-2595              69556
(888) 677-2595              69556



Latest revision as of 22:51, 29 November 2019

Public Teleconference Meeting with Exubrion Therapeutics, Inc
ML19240B518
Person / Time
Issue date: 08/28/2019
From:
Office of Nuclear Material Safety and Safeguards
To:
References
PMNS20190955
Download: ML19240B518 (3)


Text

PUBLIC MEETING ANNOUNCEMENT

Title:

Public Teleconference Meeting with Exubrion Therapeutics, Inc.

Date(s) and Time(s): September 12, 2019, 01:00 PM to 02:00 PM Location: Teleconference Category: This is a Category 1 meeting. The public is invited to observe this meeting and will have one or more opportunities to communicate with the NRC after the business portion of the meeting but before the meeting is adjourned.

Purpose:

The purpose of the meeting is to review options for Exubrion Therapeutics, Inc.'s continued discussions on the use of Sn-117m in dogs for the treatment of osteoarthritis.

Contact:

Irene Wu 301-415-1951 Irene.Wu@nrc.gov

Participants:

NRC Office of Nuclear Material Safety and Safeguards Bridge Number Pass Code Teleconference:

(888) 677-2595 69556

PUBLIC MEETING AGENDA

Public Teleconference Meeting with Exubrion Therapeutics, Inc.

September 12, 2019, 01:00 PM to 02:00 PM Teleconference

The time of the meeting is local to the jurisdiction where the meeting is being held.

The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If reasonable accommodation is needed to participate in this meeting, or if a meeting notice, transcript, or other information from this meeting is needed in another format (e.g., Braille, large print), please notify the NRC meeting contact.

Determinations on requests for reasonable accommodation will be made on a case-by-case basis.

ADAMS Accession Number: ML19240B518 OFFICIAL RECORD COPY Link to meeting details: https://www.nrc.gov/pmns/mtg?do=details&Code=20190955 Commission's Policy Statement on "Enhancing Public Participation in NRC Meetings" 67 Federal Register 36920, May 28, 2002 The policy statement may be found on the NRC website http://www.nrc.gov/reading-rm/doc-collections/commission/policy/67fr36920.html